Evolving Cardiac Electrical Therapies for Advanced Heart Failure Patients - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Circulation. Arrhythmia and electrophysiology Année : 2021

Evolving Cardiac Electrical Therapies for Advanced Heart Failure Patients

Résumé

Symptomatic heart failure (HF) patients despite optimal medical therapy and advances such as invasive hemodynamic monitoring remain challenging to manage. While cardiac resynchronization therapy remains a highly effective therapy for a subset of HF patients with wide QRS, a majority of symptomatic HF patients are poor candidates for such. Recently, cardiac contractility modulation, neuromodulation based on carotid baroreceptor stimulation, and phrenic nerve stimulation have been approved by the US Food and Drug Administration and are emerging as therapeutic options for symptomatic HF patients. This state-of-the-art review examines the role of these evolving electrical therapies in advanced HF.

Dates et versions

hal-03222533 , version 1 (10-05-2021)

Identifiants

Citer

Zain I Sharif, Vincent Galand, William J Hucker, Jagmeet P Singh. Evolving Cardiac Electrical Therapies for Advanced Heart Failure Patients. Circulation. Arrhythmia and electrophysiology, 2021, 14 (4), pp.e009668. ⟨10.1161/CIRCEP.120.009668⟩. ⟨hal-03222533⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More